NWMP
VRTX icon

Noble Wealth Management PBC’s Vertex Pharmaceuticals VRTX Stock Holding History

Noble Wealth Management PBC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.61K Buy
5
+2
+67% +$1.02K ﹤0.01% 564
2026
Q2 		$1.49K Buy
+3
New +$1.33K ﹤0.01% 632

Other funds holding VRTX

MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GGS
Galvin Gaustad & Stein Scottsdale, Arizona $1.33B AUM 13.15% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
LJHT
Laurie J. Hall Trustee $314M AUM 27.43% 1-Year Est. Return
CFG
Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return

Noble Wealth Management PBC's VRTX Position: Q3 2026 in Review

Noble Wealth Management PBC increased its Vertex Pharmaceuticals (VRTX) stake by 67% in Q3 2026, buying an estimated $1.02K and bringing the position to 5 shares worth $2.61K. The position accounts for ﹤0.01% of the portfolio, ranked #564.

Noble Wealth Management PBC first reported a position in VRTX in Q2 2026 and has held it in 2 quarters since. 66 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Noble Wealth Management PBC held 5 shares of Vertex Pharmaceuticals worth $2.61K as of Q3 2026.
  • Noble Wealth Management PBC bought 2 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.02K.
  • Vertex Pharmaceuticals made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q3 2026, its #564 holding.
  • Noble Wealth Management PBC first reported a position in Vertex Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 66 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Noble Wealth Management PBC's 13F filing for Q3 2026, filed 1 Oct 2026.